Monday, 16 April 2012 09:10
‘The treatment, which uses viruses carrying human DNA to direct the body’s natural defences against cancer cells, is the first prostate cancer vaccine ever to reach late stage “phase three” trials in Europe.
No vaccines have yet been approved in Britain to treat any type of cancer, and scientists believe it could not only double the survival rate of prostate cancer sufferers but give way to a new range of similar treatments for other tumour types.’
Read more: Prostate Cancer Vaccine Contains Genetically Modified DNA
Related posts:
Digital Dads Are Plugging In, Getting Social [INFOGRAPHIC]
'Texting lane' just for laughs, but issue serious
Spain eurozone claim irks France, Italy
Crime ‘Kill That White Man!’: 78-Year Old Man Beaten By 6 Youths in Alleged Racially-Motivated Attac...
Bit.ly Changes Again: URL Shortening Takes One Less Click
Health Highlights: June 20, 2012